about
Smart nanoparticles improve therapy for drug-resistant tumors by overcoming pathophysiological barriersTreatment of metastatic breast cancer by combination of chemotherapy and photothermal ablation using doxorubicin-loaded DNA wrapped gold nanorods.Cooperative Treatment of Metastatic Breast Cancer Using Host-Guest Nanoplatform Coloaded with Docetaxel and siRNA.Intracellularly Acid-Switchable Multifunctional Micelles for Combinational Photo/Chemotherapy of the Drug-Resistant Tumor.Silibinin and indocyanine green-loaded nanoparticles inhibit the growth and metastasis of mammalian breast cancer cells in vitro.Polydopamine-Functionalized Graphene Oxide Loaded with Gold Nanostars and Doxorubicin for Combined Photothermal and Chemotherapy of Metastatic Breast Cancer.Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer.A pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer.Cisplatin Prodrug-Conjugated Gold Nanocluster for Fluorescence Imaging and Targeted Therapy of the Breast Cancer.pH-Responsive Wormlike Micelles with Sequential Metastasis Targeting Inhibit Lung Metastasis of Breast Cancer.Shrapnel nanoparticles loading docetaxel inhibit metastasis and growth of breast cancer.Highly efficient ablation of metastatic breast cancer using ammonium-tungsten-bronze nanocube as a novel 1064 nm-laser-driven photothermal agent.Codelivery of sorafenib and curcumin by directed self-assembled nanoparticles enhances therapeutic effect on hepatocellular carcinoma.Hydrogen-bonded and reduction-responsive micelles loading atorvastatin for therapy of breast cancer metastasis.iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance.Acidity-Triggered Ligand-Presenting Nanoparticles To Overcome Sequential Drug Delivery Barriers to Tumors.Phospholipid-mimic oxaliplatin prodrug liposome for treatment of the metastatic triple negative breast cancer.Inflammatory Monocytes Loading Protease-Sensitive Nanoparticles Enable Lung Metastasis Targeting and Intelligent Drug Release for Anti-Metastasis Therapy.Hydrophobic-carbon-dot-based dual-emission micelle for ratiometric fluorescence biosensing and imaging of Cu2+ in liver cells.Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy.Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer.Photodynamic micelles for amyloid β degradation and aggregation inhibition.A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer.Simultaneous inhibition of tumor growth and angiogenesis for resistant hepatocellular carcinoma by co-delivery of sorafenib and survivin small hairpin RNA.A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors.Inhibition of Breast Cancer Metastasis by Pluronic Copolymers with Moderate Hydrophilic-Lipophilic Balance.Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.Bioreducible Micelles with Endosomal Buffering and Multidrug Resistance-Reversing Function Enhance Anti-Tumor Efficacy of Doxorubicin.Inhibition of metastasis and growth of breast cancer by pH-sensitive poly (β-amino ester) nanoparticles co-delivering two siRNA and paclitaxel.Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression.Deep Tumor-Penetrated Nanocages Improve Accessibility to Cancer Stem Cells for Photothermal-Chemotherapy of Breast Cancer Metastasis.Triplex molecular beacons for sensitive recognition of melamine based on abasic-site-containing DNA and fluorescent silver nanoclustersNanoassembly of probucol enables novel therapeutic efficacy in the suppression of lung metastasis of breast cancerCancer-Cell-Biomimetic Nanoparticles for Targeted Therapy of Homotypic TumorsDual pH-sensitive micelles with charge-switch for controlling cellular uptake and drug release to treat metastatic breast cancerAcid-Promoted D-A-D Type Far-Red Fluorescent Probe with High Photostability for Lysosomal Nitric Oxide ImagingTraceable Bioinspired Nanoparticle for the Treatment of Metastatic Breast Cancer via NIR-Trigged Intracellular Delivery of Methylene Blue and CisplatinStimuli-activatable nanomedicines for chemodynamic therapy of cancerEngineering Stimuli-Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer ImmunotherapyCocktail Strategy Based on Spatio-Temporally Controlled Nano Device Improves Therapy of Breast Cancer
P50
Q28817755-9CF4D8CE-7520-4276-AC4B-BA3F6AC7FDDEQ35201495-66DEF976-D88A-49D4-AB00-4C7138307400Q35867861-44A0BF4F-87C4-4D4E-A81A-428B6110D165Q35920735-424A77E7-2B41-4933-96AC-DF932A653868Q36004680-E1015418-9427-4228-B9BF-69147DA1AD71Q36067652-C9E27193-5CE9-4D9B-ACA2-DFC7C671F45DQ36372323-6C475300-C8FF-4381-A1F4-8881D2DC1CD6Q36534206-D01C34D4-B9EB-4552-9F16-3DA2AFF382D5Q36723759-34C2F46C-ED13-444A-AE7B-791A8BA6D7BEQ38808367-7657C912-3DEE-4858-9EE5-CE5F4C460D85Q38860587-8505662D-27F8-414F-A713-0A54DB32A3D6Q38893779-E3FBF31D-0F0C-46DB-9FDC-DC2227A54D9DQ38916427-65952135-51F9-4296-ACC0-42B53E02DAA4Q38988103-E89ABFCE-4D8C-4658-B3DC-CBE2522007D5Q39062864-1F160AA3-7B09-4BD4-B6E6-86C8B9BA594AQ46329349-1B1ED301-907D-447B-9C93-8E93FD9AC5C8Q48280114-9B128B40-1692-4E67-9EAE-7BC68628A337Q48321016-A520D8C2-7CDA-4317-B8FB-C40AB789F836Q48831420-976C8EE3-89C8-478F-B287-5F336DF19A88Q49117004-C2C4C002-225B-4BDD-AA93-2865F5196A06Q49159932-4FFD721D-9F05-4712-B70A-B3296E1C1DE6Q51144048-BB9625A9-9630-4689-AC1C-8F11E77696B3Q51732207-4B884E5B-CEA2-45D4-8B9B-2B5294D86393Q51754851-F510A24E-31EE-4614-BD80-688C009CEAA7Q52579555-D0521345-0E33-4533-BC2F-FE0E1079C9ACQ52927596-4FF82481-A435-49F1-BC3C-07363DC9943CQ52993647-B3AECE88-0605-418D-B05E-942B6B10FBF0Q53299861-9F771E25-2798-4E0A-BE9A-9CAE853AD8E9Q53609382-4113A6D3-D431-4D59-B0E7-F9994E4E9D13Q53641360-DC81FCFF-33CF-45F8-B888-2ED819878E20Q64947408-A9E2A337-1CA2-4C95-A04E-C892AE762B3EQ87100272-2A60C7E3-F1A4-487F-8E8B-912CF8B94F07Q88082644-717D8BB3-C77F-4FEC-BB9E-FEDD5B1313E3Q88332382-6A03E700-7702-48D5-B164-48698DB5AA81Q88759788-499B824A-25F1-4756-9BA7-5C3855D26761Q89061757-24A2BFF6-5AA4-4DF9-B8FF-B95F8B51CF5FQ89493702-2C8753AF-37D2-40D9-B113-FF7F8E300D43Q89500142-C5F8650A-62A6-4968-99D8-22C6C6ACFDF8Q89671053-3B4E3BD0-0165-4BE0-B53E-5340A0010DE2Q90273854-78754298-3ED9-4AA1-837C-2C5E34973102
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Haijun Yu
@ast
Haijun Yu
@en
Haijun Yu
@es
Haijun Yu
@nl
Haijun Yu
@sl
type
label
Haijun Yu
@ast
Haijun Yu
@en
Haijun Yu
@es
Haijun Yu
@nl
Haijun Yu
@sl
prefLabel
Haijun Yu
@ast
Haijun Yu
@en
Haijun Yu
@es
Haijun Yu
@nl
Haijun Yu
@sl
P1053
C-5343-2016
P106
P1153
56179219100
P2038
Haijun_Yu2
P31
P3829
P496
0000-0002-3398-0880
P569
2000-01-01T00:00:00Z